Information on the Target

Modern Baker is an innovative food-tech company that has raised £2.5 million in a Series A funding round, spearheaded by Adjuvo. This investment is fundamental in supporting the company’s mission to revolutionize ultra-processed foods, transforming them into healthier choices that can be incorporated into daily diets without compromising on taste, convenience, or manufacturing efficiency. The company has developed a unique, ingredient-led technology platform, alongside fully licensable intellectual property (IP) that empowers food manufacturers to create healthier staples.

Modern Baker is addressing the challenge of ultra-processed foods (UPFs) by showing that such products can be part of the solution to enhancing population health. Their adaptable platform enables rapid innovation across various food categories, which presents vast opportunities for both food manufacturers and consumers. A key product from Modern Baker, SUPERLOAF, has already launched in major retailers including Marks & Spencer, Sainsbury’s, and Ocado Retail, showcasing significant benefits in blood glucose management and gut health.

Industry Overview in the Target’s Specific Country

The food-tech industry in the United Kingdom is experiencing transformative growth, driven by increasing consumer demand for healthier options and the rise of innovative food technologies. Health-conscious trends are prompting food manufacturers to innovate their product offerings, particularly in addressing the challenges of ultra-processed foods. This shift is also supported by government initiatives aimed at improving public health through diet and nutrition, which further encourages investment in health-oriented food technologies.

Moreover, with consumers becoming more aware of the health implications of their food choices, there is a substantial market for products that blend convenience with nutritional value. Modern Baker's mission is particularly resonant in the context of the UK’s ongoing efforts to tackle health issues linked to poor diets, such as obesity and diabetes.

The UK's food industry is also witnessing an increase in collaboration between tech companies and traditional food manufacturers. This synergistic relationship fosters innovation, as seen with Modern Baker’s licensing model that allows for established infrastructure to support new health-centric products without the need for extensive overhauls in production processes. The successful integration of technology in food manufacturing is reshaping how health benefits can be delivered at scale.

In summary, the current landscape of the UK food industry is supportive of innovative approaches that enhance health outcomes, making it an ideal environment for Modern Baker to expand its impact and effectiveness. The focus on healthier alternatives presents numerous opportunities for growth within the sector.

The Rationale Behind the Deal

The decision by Adjuvo to invest in Modern Baker is rooted in the shared vision of addressing significant public health issues through innovative food solutions. This partnership provides Modern Baker with the financial resources necessary to scale their platform and reach a broader consumer base while maintaining product quality and health benefits. Additionally, the investment aligns with Adjuvo's strategic objective of supporting companies that leverage technology and science to create impactful societal benefits.

By backing Modern Baker, Adjuvo believes they are investing in a disruptor that can redefine the perception and utility of ultra-processed foods. The collaborative potential between Modern Baker and traditional food manufacturers via licensing agreements further accentuates the strategic nature of this investment, enabling faster market entry and broad adoption of healthier food options.

Information About the Investor

Adjuvo is a venture capital firm committed to fostering innovative companies that aim to tackle critical societal challenges through technology and scientific advancements. With a keen focus on the food-tech sector, Adjuvo invests in businesses that demonstrate commercial viability alongside the potential for societal impact. Mark Foster-Brown, CEO of Adjuvo, emphasizes the firm's dedication to supporting disruptive innovations that enrich public health outcomes.

Through their partnership with Modern Baker, Adjuvo is positioning itself at the forefront of a movement that seeks to enhance the nutritional profile of everyday foods. The firm not only provides capital but also strategic guidance and industry connections, ensuring that its portfolio companies thrive and generate a meaningful impact.

View of Dealert

The potential for Modern Baker to succeed in the food-tech industry is substantial, especially given its unique approach to transforming ultra-processed foods. The combination of a strong technological platform and the ability to forge licensing agreements with established manufacturers presents a formidable strategy for scaling. By addressing health concerns while ensuring taste and convenience, Modern Baker is well-positioned to capture market share among increasingly health-conscious consumers.

Furthermore, the backing from Adjuvo lends credibility and expertise that can accelerate the company’s growth trajectory. The focus on innovations that deliver significant health benefits and the ability to quickly adapt to various food categories provides a competitive edge in a growing industry. With projects like SUPERLOAF already in major retail channels, the market validation is clear.

However, the landscape is also competitive, with numerous players vying for attention in the food-tech space. Modern Baker will need to continuously innovate and effectively communicate the health benefits of its products to maintain consumer interest and loyalty. The ongoing consumer shift towards health-conscious products establishes a favorable market environment, yet execution will be key.

In conclusion, Adjuvo's investment in Modern Baker has strong potential, offering both financial backing and strategic support to a company poised to lead meaningful change in the food industry. If Modern Baker successfully executes its growth strategy and continues to leverage its innovative technology, it could significantly impact public health and contribute to reshaping consumer perceptions of ultra-processed foods.

View Original Article

Similar Deals

ProVen VCTs Farmer J

2024

Series A Food & Drug Retailing United Kingdom
Active Partners KatKin

2023

Series A Food & Drug Retailing United Kingdom
Saudi Industrial Investment Group Unibio International

2023

Series A Food & Drug Retailing United Kingdom
Project Eaden Project Eaden

2023

Series A Food & Drug Retailing United Kingdom
Joyful Ventures Meatly

2023

Series A Food & Drug Retailing United Kingdom
Adjuvo Modern Baker

Series A Food & Drug Retailing United Kingdom
Imbiba Openr

2025

Series A Software & IT Services United Kingdom
Foresight Group and the Development Bank of Wales Nisien.AI

2025

Series A Software & IT Services United Kingdom
AlbionVC Ionate

2025

Series A Software & IT Services United Kingdom
IP Group AccelerComm

2025

Series A Telecommunications Services United Kingdom

Adjuvo

invested in

Modern Baker

in

in a Series A deal

Disclosed details

Transaction Size: $3M

Deal Parametres
Industry
Country
Seller type

Sign Up to Dealert